IL-6, a key mediator of OSA-associated morbidity, was found to be elevated in adipose tissue and plasma of obese OSA patients, with levels being attenuated by CPAP therapy [93]. The gene discussed is IL6; the disease is obstructive sleep apnea syndrome.